Liquid antimicrobials: a national analysis of critical shortages

Eur J Hosp Pharm. 2024 Feb 1:ejhpharm-2023-004032. doi: 10.1136/ejhpharm-2023-004032. Online ahead of print.

Abstract

Medicine shortages, especially those involving antibiotics, pose a global public health dilemma that can lead to adverse health outcomes. The aim of this study was to assess the supply situation of various antimicrobials in liquid dosage forms, which represent the mainstay of therapy for paediatric infections. The availability was examined over a period of 27 weeks in Austria. During the time period investigated, 34 products (81.0%) were not available for over 50% of the time; eight of those (19.0%) experienced complete unavailability. Only four products (9.5%) demonstrated continuous availability. Regarding penicillin antibiotics, amoxicillin was not available for 77.8% of the time (21 weeks) and amoxicillin/clavulanic acid for 59.3% (16 weeks). Regular monitoring of availability status can help mitigate this issue; however, cross-national strategies are urgently needed to guarantee a constant supply in the future.

Keywords: Drug Substitution; EVIDENCE-BASED MEDICINE; Organization and Administration; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; PUBLIC HEALTH; Quality Assurance, Health Care; Quality of Health Care; Safety.